Injectafer [Prescribing Information]. Shirley, NY: American Regent, Inc. Ap. ○ Ferrlecit [Prescribing Information]. Bridgewater
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Injectafer safely and effectively. See full prescribing information for Injectafer. INJECTAFER (ferric carboxymaltoseinjection), for intravenous use Initial U.S. Approval: 2024
Injectafer for intravenous use [prescribing information]. Shirley, NY: American Regent; April 2024. 2. Venofer injection [prescribing
The majority of patients (93 to 95 percent) in trials of Injectafer received the target dose of 1500 mg. The full prescribing information for Injectafer is
Sections or subsections omitted from the full prescribing information are not . General information about using INJECTAFER safely and effectively.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Injectafer safely and effectively. See full prescribing information for Injectafer. INJECTAFER (ferric carboxymaltose injection), for intravenous use Initial U.S. Approval: 2024
See full prescribing information for Injectafer. INJECTAFER (ferric carboxymaltose injection), for intravenous use. Initial U.S. Approval
Injectafer safely and effectively. See full prescribing information for Injectafer. INJECTAFER (ferric carboxymaltose injection) For intravenous use Initial U.S. Approval: 20XX -INDICATIONS AND USAGE- Injectafer is an iron replacement product indicated for the treatment of iron
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Injectafer safely and effectively. See full prescribing information for Injectafer. INJECTAFER (ferric carboxymaltose injection), for intravenous use Initial U.S. Approval: 2024
Comments
SHOULD BE:
Andy had literally simply RELAYED all the various information.